Skip to main content
Clinical Trials/NCT03297762
NCT03297762
Terminated
Not Applicable

Improving Adherence to Continuous Glucose Monitors in Publicly-insured Youth With Type 1 Diabetes

Stanford University1 site in 1 country4 target enrollmentMay 7, 2018
ConditionsType1diabetes

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Type1diabetes
Sponsor
Stanford University
Enrollment
4
Locations
1
Primary Endpoint
CGM use
Status
Terminated
Last Updated
6 years ago

Overview

Brief Summary

To use an enhanced continuous glucose monitor (CGM) experience, including an automated CGM-electronic health record (EHR) data integration system, proactive interventions, and gamification techniques, to increase CGM use among publicly-insured youth with type 1 diabetes (T1D).

Detailed Description

The investigators will use an automated data integration system to monitor hours per week the CGM is worn and target interventions/troubleshooting techniques as needed. The investigators will use gamification techniques (i.e. ability to gain points and achieve small rewards) to help encourage CGM use and potentially improve glycemic control in this at-risk population.

Registry
clinicaltrials.gov
Start Date
May 7, 2018
End Date
June 1, 2019
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Darrell M Wilson

Professor of Pediatrics

Stanford University

Eligibility Criteria

Inclusion Criteria

  • type 1 diabetes for more than 6 months
  • on insulin pump or multiple daily injections without plans to change modality in next 6 months
  • insured by CCS or Medi-Cal
  • receiving care at Lucile Packard Children's Hospital or Stanford Children's Health outpatient clinics
  • English or Spanish-speaking

Exclusion Criteria

  • major illness or condition that may alter glucose control or ability to complete the study including pregnancy, cystic fibrosis, cancer, liver disease, history of transplant, or hemoglobinopathy
  • current oral glucocorticoid use
  • prior use of a CGM system
  • hemoglobin A1C \<7.5% or \>12%
  • no wireless internet access

Outcomes

Primary Outcomes

CGM use

Time Frame: baseline to 6 months

amount of time per week CGM is used

Secondary Outcomes

  • Hgb A1c(baseline to 6 months)

Study Sites (1)

Loading locations...

Similar Trials